LYELL IMMUNOPHARMA INC
LYEL·55083R104·UQ·Common Stock·Healthcare - Biotechnology-13D/G
LYEL (LYELL IMMUNOPHARMA INC) is held by 57 institutional investors as of Q2 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($11.1M), BlackRock, Inc. ($10.2M), MILLENNIUM MANAGEMENT LLC ($5.2M). Net institutional sentiment: Bullish.
57
Holders
(2 Elite)
$58.2M
Total Value
67% (55)
Consensus
37 buying - 18 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Oct 12, 2026 · Insiders Sep 10, 2026 · Activists Aug 19, 2025 · Congress none
InsiderSDShook DavidSell $6KSep 10, 2026
InsiderLKLee Gary K.Sell $23KAug 21, 2026
InsiderHJHill Stephen J.Sell $15KAug 21, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 61
1 / 4
Continue exploring
Other Healthcare stocks held by institutions
417 holders · $300.5B
416 holders · $881.6B
401 holders · $151.5B
398 holders · $415.6B
395 holders · $98.9B
394 holders · $111.8B
391 holders · $230.3B
386 holders · $303.9B
386 holders · $52.4B
383 holders · $114.2B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer